ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OMH Osmetech

2.15
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Osmetech LSE:OMH London Ordinary Share GB00B0K29R51
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.15 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Holding(s) in Company

20/01/2010 12:19pm

UK Regulatory



 

TIDMOMH 
 
RNS Number : 8530F 
Osmetech PLC 
20 January 2010 
 

20 January 2010 
Osmetech PLC ('Osmetech' or 'the Company') 
Disclosure of Significant Shareholding 
 
On 1 December 2009, Osmetech posted a circular to its shareholders 
(the "Circular") regarding , inter alia, a proposed Placing. Contained within 
the Circular were certain disclosures regarding holdings in the Company of Dr 
Kayyem, a director of the Company. The Circular stated: 
"The exact number of Ordinary Shares that Dr Kayyem will beneficially own as a 
result of Efficacy's participation in the Placing cannot be completely 
determined until Efficacy has completed its own internal reporting and will be 
able to inform Dr Kayyem of his exact beneficial holding in the Company". 
Dr Kayyem has informed the Company that the internal reporting at Efficacy is 
now complete and Dr Kayyem has subsequently transferred out all of his 
beneficial holdings in Osmetech previously held with Efficacy. Dr Kayyem has 
confirmed he holds a beneficial holding in the 
Company totalling 116,355,087 Ordinary Shares, representing 7.12% of the current 
issued share capital of the Company, and none of which are now held through 
Efficacy. 
 
 
For the avoidance of doubt, Dr Kayyem has not bought or sold any Ordinary Shares 
in the Company since participating in the Placing as described in the Circular. 
As a result of Dr Kayyem transferring out his beneficial holdings in Osmetech 
from Efficacy, Efficacy now has a disclosable interest in the Company of 
201,915,914 Ordinary Shares, representing 12.36% of the current issued share 
capital of the Company. 
The total number of issued Ordinary Shares is 1,633,443,351. Osmetech does not 
hold any Ordinary Shares in Treasury. Therefore, the total number of voting 
rights in Osmetech is 1,633,443,351. 
Unless otherwise sated, all defined terms in this announcement shall have the 
same meaning as those in the  Circular of 01 December 2009. 
 
 
For further information: 
 
+----------------------+----------+ 
| Osmetech             | +44 (0)  | 
| plc:                 | 20 7849  | 
|                      | 6027     | 
+----------------------+----------+ 
| David                |          | 
| Sandilands,          |          | 
| Finance              |          | 
| Director             |          | 
+----------------------+----------+ 
|                      |          | 
+----------------------+----------+ 
|                      |          | 
+----------------------+----------+ 
| Canaccord            | +44 (0)  | 
| Adams                | 20 7050  | 
| Limited:             | 6500     | 
+----------------------+----------+ 
| Robert               |          | 
| Finlay               |          | 
+----------------------+----------+ 
| Henry                |          | 
| Fitzgerald-O'Connor  |          | 
+----------------------+----------+ 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 HOLSEWFESFSSEFF 
 

1 Year Osmetech Chart

1 Year Osmetech Chart

1 Month Osmetech Chart

1 Month Osmetech Chart

Your Recent History

Delayed Upgrade Clock